ETOP

ETOP IBCSG Partners Foundation is a leading Swiss-based academic research organization (ARO) and non-profit foundation dedicated to advancing cancer research through international clinical trials. Formed by the merger of the European Thoracic Oncology Platform (ETOP) and the International Breast Cancer Study Group (IBCSG), the entity coordinates a vast network of researchers and institutions across the globe. The foundation focuses primarily on thoracic and breast cancers, conducting high-impact Phase 1 through Phase 3 trials that evaluate novel targeted therapies and immunotherapies. By integrating translational research and clinical data, ETOP IBCSG aims to define new standards of care and promote precision medicine in oncology. The organization maintains strong collaborations with major pharmaceutical companies and academic centers to facilitate the development of innovative treatment strategies.